FundingWatcher
Home / Investors / Biotech investors / Biotech investors in Massachusetts, United States

Biotech investors in Massachusetts, United States

Updated 16 Nov 2026

Reset

Venture funds

5 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Mission BioCapital
Mission BioCapital invests in early-stage life science companies, with recent investments including Circle Pharma and Cloverleaf Bio.
Cambridge, United States
Biotech, Health care Seed, Early stage venture, Late stage venture 20% 4
2 F-Prime
F-Prime invests in healthcare and technology, with recent companies including Albert Invent and Nocion Therapeutics.
Cambridge, United States
Health care, Fintech Seed, Early stage venture, Late stage venture 25% 2
3 MassVentures
MassVentures supports Massachusetts-based startups, with recent backings including Emvolon and EnVision Endoscopy.
Boston, United States
Health care, Hardware Seed, Early stage venture, Late stage venture 26% 2
4 Morningside
Morningside invests in companies with novel science and technology, recently backing Pelicargo and Cognito Therapeutics.
Newton, United States
Health care, Biotech 46% 2
5 The Engine
The Engine supports new companies working on scientific and technological innovation, with recent companies including Hyperlight and Emvolon.
Cambridge, United States
Hardware, Health care Seed, Early stage venture 36% 2

Table 1. Biotech investors in Massachusetts, United States: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in Massachusetts, United States
One-time CSV
  • 58 firms, 57 with a website
  • 39 firm email addresses
  • 33 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-massachusetts-united-states.csv58 rows × 15 columns
InvestorTypeLocationEmailPhone
RA Capital ManagementStartup incubatorBoston, United States•••@racap.com617.77•••
MassChallengeStartup acceleratorBoston, United States•••@masschallenge.org
F-PrimeVenture capital firmCambridge, United States•••@fprimecapital.com
Polaris PartnersPrivate equity firmBoston, United States•••@polarispartners.com+1 855•••
Omega FundsSecondary purchaserBoston, United States•••@omegafunds.net
MPM CapitalPrivate equity firmBoston, United States•••@mpmcapital.com+1 617•••
Mission BioCapitalVenture capital firmCambridge, United States•••@missionbiocapital.com+1 617•••
Atlas VentureVenture capital firmCambridge, United States•••@atlasventure.com857 20•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-sector-biotech-massachusetts-united-states-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
RA Capital ManagementP••• K•••Managing Partnerp•••@racap.comIn the CSV
F-PrimeS••• J•••General Partner and Co-Founder, Investing in AI Native Software s•••@fprimecapital.comIn the CSV
Polaris PartnersJ••• F•••Founding Partnerj•••@polarispartners.comIn the CSV
MPM CapitalC••• B••• M•••Co Managing Partnerc•••@mpmcapital.comIn the CSV
Mission BioCapitalS••• T•••Managing General Partners•••@missionbiocapital.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

58
Investors
39
With email
33
With phone
39
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in Massachusetts, United States

30 of 58, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 RA Capital Management Startup incubator, Private equity firm Boston, United States Health care, Biotech Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics 9 544 183 243 •••@racap.com 617.77••• In the CSV
2 MassChallenge Startup accelerator Boston, United States Artificial intelligence, Health care HELIOS, DrizzleX, ScribeUp 26 3,225 1,037 267 •••@masschallenge.org In the CSV
3 F-Prime Venture capital firm Cambridge, United States Health care, Fintech T-Therapeutics, Albert Invent, Immuneel Therapeutics 4 540 133 113 •••@fprimecapital.com In the CSV
4 Polaris Partners Private equity firm, Venture capital firm Boston, United States Health care, Artificial intelligence Faro AI, Triveni Bio, Whisker Labs 3 754 215 207 •••@polarispartners.com +1 855••• In the CSV
5 Fidelity Investment bank Boston, United States Health care, Hardware Zipline International, Tenstorrent, SiMa.ai 7 586 178 285 +1-866••• In the CSV
6 Cormorant Asset Management Hedge fund Boston, United States Health care, Biotech Triveni Bio, Third Arc Bio, BlossomHill Therapeutics 4 276 58 141 In the CSV
7 Omega Funds Secondary purchaser, Venture capital firm Boston, United States Biotech, Health care FoRx Therapeutics 1 161 37 75 •••@omegafunds.net In the CSV
8 MPM Capital Private equity firm, Venture capital firm Boston, United States Biotech, Health care Reunion Neuroscience, Umoja Biopharma, āshibio 301 97 105 •••@mpmcapital.com +1 617••• In the CSV
9 Morningside Private equity firm, Venture capital firm Newton, United States Health care, Biotech Pelicargo, Zhide New Energy, Cognito Therapeutics 4 138 64 23 In the CSV
10 Johnson & Johnson Innovation Corporate venture arm Cambridge, United States Health care, Biotech ONL Therapeutics, Flindr Therapeutics, Asgard Therapeutics 118 39 26 In the CSV
11 Mission BioCapital Venture capital firm Cambridge, United States Biotech, Health care Circle Pharma, Cloverleaf Bio, Integrated Biosciences 4 85 17 19 •••@missionbiocapital.com +1 617••• In the CSV
12 Atlas Venture Venture capital firm Cambridge, United States Health care, Biotech Diagonal Therapeutics 1 638 179 199 •••@atlasventure.com 857 20••• In the CSV
13 Wellington Management Private equity firm, Venture capital firm Boston, United States Fintech, Health care Tabby, Current, Element Biosciences 4 335 111 160 •••@wellington.com 617-95••• In the CSV
14 SV Health Investors Private equity firm, Venture capital firm Boston, United States Health care, Biotech Alchemab Therapeutics 1 325 76 95 •••@svlsa.com +1 617••• In the CSV
15 Bain Capital Life Sciences Private equity firm, Venture capital firm Boston, United States Biotech, Health care CereVasc 1 117 41 60 •••@baincapital.com
16 Bantam Group Angel group, Venture capital firm Westwood, United States Artificial intelligence, Hardware Drive lah, Aikium Inc. 2 166 0 46 •••@bantamgroup.com 781-32•••
17 Third Rock Ventures Venture capital firm Boston, United States Biotech, Health care Terremoto Biosciences 1 154 69 44 •••@thirdrockventures.com (415) ••• In the CSV
18 Half Court Ventures Venture capital firm Boston, United States Artificial intelligence, Hardware Light Frame, Flow Labs, Beacon Biosignals 4 89 1 17 In the CSV
19 Taihill Venture Venture capital firm Boston, United States Biotech, Artificial intelligence Kano Therapeutics, Bot Auto, LeyLine 65 2 4 •••@taihill.vc In the CSV
20 MassVentures Venture capital firm Boston, United States Health care, Hardware Emvolon, ZwitterCo, Kytopen 6 476 122 83 •••@mass-ventures.com +1 617••• In the CSV
21 Flagship Pioneering Venture capital firm Cambridge, United States Biotech, Health care Inari, Prologue Medicines, Quotient Therapeutics 288 104 72 617-86••• In the CSV
22 Pillar VC Venture capital firm Boston, United States Artificial intelligence, Health care Addis Energy, OpenHands 2 149 26 18 •••@pillar.vc 857-40••• In the CSV
23 PharmStars Startup accelerator Boston, United States Health care, Artificial intelligence Triomics, Medra AI 2 68 62 4 In the CSV
24 Vida Ventures Venture capital firm Boston, United States Biotech, Health care InduPro 1 67 23 25 •••@vidaventures.com 857-25••• In the CSV
25 Innospark Ventures Venture capital firm Boston, United States Artificial intelligence, Biotech VODA.ai, Persist AI, VideaHealth 56 18 5 In the CSV
26 E14 Fund Micro VC fund Cambridge, United States Artificial intelligence, Hardware Ramona 1 112 12 11 •••@e14fund.com +1 617••• In the CSV
27 The Engine Venture capital firm Cambridge, United States Hardware, Health care Emvolon, Hyperlight, Kytopen 4 81 29 3 •••@engine.xyz In the CSV
28 Broadview Ventures Venture capital firm Boston, United States Health care, Biotech CroíValve 1 75 19 12 •••@broadviewventures.org 617-34••• In the CSV
29 Longwood Fund Venture capital firm Boston, United States Health care, Biotech Channel Medsystems 1 74 11 19 •••@longwoodfund.com (617)3••• In the CSV
30 BDC Capital Corporation Venture capital firm, Venture debt fund Wakefield, United States Hardware, Biotech Brickeye 1 64 15 29 •••@bdcnewengland.com 207-77••• In the CSV

Table 2. Biotech investors in Massachusetts, United States: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 58.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 MassChallenge Boston, United States 26 325 HELIOS, DrizzleX, ScribeUp
2 RA Capital Management Boston, United States 9 47 Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics
3 Fidelity Boston, United States 7 40 Zipline International, Tenstorrent, SiMa.ai
4 MassVentures Boston, United States 6 35 Emvolon, ZwitterCo, Kytopen
5 Half Court Ventures Boston, United States 4 32 Light Frame, Flow Labs, Beacon Biosignals
6 F-Prime Cambridge, United States 4 75 T-Therapeutics, Albert Invent, Immuneel Therapeutics
7 The Engine Cambridge, United States 4 9 Emvolon, Hyperlight, Kytopen
8 Mission BioCapital Cambridge, United States 4 8 Circle Pharma, Cloverleaf Bio, Integrated Biosciences
9 Wellington Management Boston, United States 4 39 Tabby, Current, Element Biosciences
10 Morningside Newton, United States 4 26 Pelicargo, Zhide New Energy, Cognito Therapeutics
11 Cormorant Asset Management Boston, United States 4 13 Triveni Bio, Third Arc Bio, BlossomHill Therapeutics
12 Polaris Partners Boston, United States 3 73 Faro AI, Triveni Bio, Whisker Labs
13 Glasswing Ventures Boston, United States 3 24 Enlaye, Lambent, Allure Security Technology
14 Mass General Brigham Ventures Cambridge, United States 2 4 Claris Biotherapeutics, InStride Health
15 PharmStars Boston, United States 2 12 Triomics, Medra AI

Table 3. Biotech investors in Massachusetts, United States: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Light Frame Light Frame builds core banking and portfolio management technology for wealth managers. Fintech Providence, United States Seed $5.1M 2026-11-10 $6.8M Half Court Ventures 1 to 10 2024
Delix Therapeutics Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. Biotech Boston, United States Series C $100.0M 2026-11-09 $244.1M RA Capital Management 11 to 50 2019
Zipline International Unicorn Zipline designs, manufactures, and operates drones that deliver medical products. Hardware South San Francisco, United States Series I $1.5B 2026-11-05 $3.6B Fidelity 1,001 to 5,000 2011
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime 51 to 100 2022
HELIOS HELIOS provides an AI-powered hockey platform that uses wearable sensors and video to measure player development. Artificial intelligence Portsmouth, United States Seed $1.1M 2026-11-03 $3.9M MassChallenge 11 to 50 2018
Emvolon Emvolon converts wasted resources into low-cost green fuels. Energy Woburn, United States Series A $22.0M 2026-10-27 $24.5M MassVentures, The Engine 11 to 50 2021
DrizzleX DrizzleX addresses water waste in apartment buildings. Software Santa Fe Springs, United States Series A $6.8M 2026-10-20 $12.3M MassChallenge 11 to 50 2019
Tenstorrent Unicorn Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. Artificial intelligence Santa Clara, United States Series E $1.5B 2026-10-19 $2.5B Fidelity 501 to 1,000 2016
ScribeUp ScribeUp embeds subscription management into banking products for fintechs, banks, and credit unions. Commerce Los Angeles, United States Series A $10.0M 2026-10-19 $16.0M MassChallenge 11 to 50 2021
MuukTest MuukTest provides an AI-powered software testing platform that helps developers test their software faster. Artificial intelligence Raleigh, United States Seed $499K 2026-10-14 $7.0M MassChallenge 11 to 50 2019

Table 4. Biotech investors in Massachusetts, United States: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 763 68%
Health care 368 33%
Artificial intelligence 272 24%
Biotech 256 23%
Hardware 192 17%
Fintech 131 12%
Commerce 95 8%
Cybersecurity 54 5%
Education 50 4%
Energy 31 3%

Table 5. Biotech investors in Massachusetts, United States: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Investment stagesInvestorsShare
Early stage investors 53 91%
Seed investors 42 72%
Late stage investors 31 53%
Venture investors 29 50%
Private equity investors 17 29%
Post IPO investors 15 26%
Debt investors 9 16%
Grant makers 4 7%

Table 6. Biotech investors in Massachusetts, United States by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
Boston 33 57%
Cambridge 17 29%
Newton 2 3%
Waltham 2 3%
Westwood 1 2%
Wakefield 1 2%
Natick 1 2%
Lexington 1 2%

Table 7. Biotech investors in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 7 12%
2010s 20 36%
2000s 13 23%
1990s 5 9%
1980s 5 9%
1970s 2 4%

Table 8. Biotech investors in Massachusetts, United States by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in Massachusetts, United States are on the list?
58, in the file dated 16 November 2026. 39 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
39 of the 58 carry an email address in the download and 33 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 58 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 58 rows, 39 firm email addresses and 33 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 19 of the 39 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in Massachusetts, United States: 58 rows, CSV, $29 one-time.

At once: the CSV with 58 rows, 39 firm email addresses and 33 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 19 of the 39 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech investors by city in Massachusetts

Investor types in Massachusetts

Other portfolio sectors in Massachusetts

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 58 biotech investors in Massachusetts, United States, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/massachusetts-united-states/